The likely first longevity drug is based on sketchy science. This is bad for science and bad for longevity.

13/12/2023 9 min
The likely first longevity drug is based on sketchy science. This is bad for science and bad for longevity.

Listen "The likely first longevity drug is based on sketchy science. This is bad for science and bad for longevity."

Episode Synopsis

If you are interested in the longevity scene, like I am, you probably have seen press releases about the dog longevity company, Loyal for Dogs, getting a nod for efficacy from the FDA. These have come in the form of the New York Post calling the drug "groundbreaking", Science Alert calling the drug "radical", and the more sedate New York Times just asking, "Could Longevity Drugs for Dogs Extend Your Pet's Life?", presumably unaware of Betteridge's Law of Headlines. You may have also seen the coordinated Twitter offensive of people losing their shit about this, including their lead investor, Laura Deming, saying that she "broke down crying when she got the call".And if you have been following Loyal for Dogs for a while, like I have, you are probably puzzled by this news. Loyal for Dogs has been around since 2021. Unlike any other drug company or longevity [...]--- First published: December 12th, 2023 Source: https://www.lesswrong.com/posts/vHSkxmYYqW59sySqA/the-likely-first-longevity-drug-is-based-on-sketchy-science --- Narrated by TYPE III AUDIO.

More episodes of the podcast LessWrong (Curated & Popular)